World Library  


Add to Book Shelf
Flag as Inappropriate
Email this Book

Plos One : Epidermal Growth Factor Receptor Egfr-ras Signaling Pathway in Penile Squamous Cell Carcinoma, Volume 8

By Viglietto, Giuseppe

Click here to view

Book Id: WPLBN0003947876
Format Type: PDF eBook :
File Size:
Reproduction Date: 2015

Title: Plos One : Epidermal Growth Factor Receptor Egfr-ras Signaling Pathway in Penile Squamous Cell Carcinoma, Volume 8  
Author: Viglietto, Giuseppe
Volume: Volume 8
Language: English
Subject: Journals, Science, Medical Science
Collections: Periodicals: Journal and Magazine Collection
Historic
Publication Date:
Publisher: Plos

Citation

APA MLA Chicago

Viglietto, G. (n.d.). Plos One : Epidermal Growth Factor Receptor Egfr-ras Signaling Pathway in Penile Squamous Cell Carcinoma, Volume 8. Retrieved from http://www.ebooklibrary.org/


Description
Description : Penile Squamous Cell Carcinoma (SCC) is a rare cancer with poor prognosis and limited response to conventional chemotherapy. The genetic and epigenetic alterations of Epidermal Growth Factor Receptor (EGFR)-RAS-RAF signaling in penile SCC are unclear. This study aims to investigate four key members of this pathway in penile SCC. We examined the expression of EGFR and RAS-association domain family 1 A (RASSF1A) as well as the mutation status of K-RAS and BRAF in 150 cases of penile SCC. EGFR and RASSF1A expression was evaluated by immunohistochemistry. KRAS mutations at codons 12 and 13, and the BRAF mutation at codon 600 were analyzed on DNA isolated from formalin fixed paraffin embedded tissues by direct genomic sequencing. EGFR expression was positive in all specimens, and its over-expression rate was 92%. RASSF1A expression rate was only 3.42%. Significant correlation was not found between the expression of EGFR or RASSF1A and tumor grade, pT stage or lymph node metastases. The detection of KRAS and BRAF mutations analysis was performed in 94 and 83 tumor tissues, respectively. We found KRAS mutation in only one sample and found no BRAF V600E point mutation. In summary, we found over-expression of EGFR in the majority cases of penile SCC, but only rare expression of RASSF1A, rare KRAS mutation, and no BRAF mutation in penile SCC. These data suggest that anti-EGFR agents may be potentially considered as therapeutic options in penile SCC

 

Click To View

Additional Books


  • Plos One : Dual Involvement of Growth Ar... (by )
  • Plos One : Targeted Biomarker Discovery ... (by )
  • Plos One : Resveratrol Confers Protectio... (by )
  • Plos One : Moment Approximation of Infec... (by )
  • Plos One : United States Acculturation a... (by )
  • Plos One : Effect of Maternal Methionine... (by )
  • Plos One : Ddra, Ddrd, and Ppra ; Compon... (by )
  • Plos One : Beneficial Effects of Wheat G... (by )
  • Plos One : Characterization of the Holli... (by )
  • Plos One : Propolis Augments Apoptosis I... (by )
  • Plos One : Mimicking P14Arf Phosphorylat... (by )
  • Plos One : Diversity and Succession of B... (by )
Scroll Left
Scroll Right

 



Copyright © World Library Foundation. All rights reserved. eBooks from World eBook Library are sponsored by the World Library Foundation,
a 501c(4) Member's Support Non-Profit Organization, and is NOT affiliated with any governmental agency or department.